Treatment of stroke on an intensive stroke unit: A novel concept

Intensive Care Medicine

Volumn 26, Issue 11, 2000, Pages 1598-1611

  Treib, J ^a   Grauer, M T ^a   Woessner, R ^a   Morgenthaler, M ^a  

^a Westpfalz Klinikum GmbH   (Germany)

Author keywords

Intracranial bleeding; Stroke; Stroke unit; Therapy; Treatment

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CITICOLINE; CLOPIDOGREL; COUMARIN ANTICOAGULANT; DALTEPARIN; DIPYRIDAMOLE; ELIPRODIL; ENOXAPARIN; FIBRINOLYTIC AGENT; GAVESTINEL; GLYCEROL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; LUBELUZOLE; MAGNESIUM; MANNITOL; NEUROPROTECTIVE AGENT; NIMODIPINE; PIRACETAM; PLASMA SUBSTITUTE; SORBITOL; STREPTOKINASE; TICLOPIDINE; TIRILAZAD; TISSUE PLASMINOGEN ACTIVATOR; TROMETAMOL; UNINDEXED DRUG; UROKINASE;

ANTICOAGULATION; BLOOD CLOT LYSIS; BRAIN EDEMA; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DECOMPRESSION SURGERY; FLUID THERAPY; GERMANY; HEALTH CARE COST; HEPARINIZATION; HUMAN; HYPOTHERMIA; INTENSIVE CARE UNIT; MOBILIZATION; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; THROMBOCYTE AGGREGATION INHIBITION; VEIN THROMBOSIS;

CEREBROVASCULAR ACCIDENT; CRANIOTOMY; DECOMPRESSION, SURGICAL; DIAGNOSIS, DIFFERENTIAL; FLUID THERAPY; GERMANY; HUMANS; INTENSIVE CARE UNITS; INTRACRANIAL HEMORRHAGES; THROMBOLYTIC THERAPY;

EID: 0033660199     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340000667     Document Type: Review

References (116)

1. Epidemiology of stroke
2. Collaborative systematic review of randomised trials of organised inpatient (stroke unit) care after stroke
3. The effect of a stroke unit: Reductions in mortality, discharge rate to nursing home, length of hospital stay and cost
4. Stroke unit treatment 10-year follow-up
5. Empfehlungen fur die einrichtung von schlaganfall-spezialstationen ('stroke units')-aktualisierungen 1997
6. Behandlung des ischamischen insultes
7. Behandlung des akuten ischamischen insultes
8. Increased damage after ischemic stroke in patients with hyperglycaemia with or without established diabetes mellitus
9. Admission glucose levels in relation to mortality and morbidity outcome in 252 stroke patients
10. Hyperglycemia after acute stroke
11. Effect of blood pressure and diabetes on stroke in progression
12. Brain temperature monitoring and modulation in patients with severe ischemic stroke
13. Intensive care in acute stroke
14. Early hemicranectomy in patients with complete middle cerebral artery infarction
15. Lowdose heparin as a prophylaxis against deep-vein thrombosis after acute stroke
16. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke
17. Autoregulation of cerebral blood flow: Influence of arterial blood pressure on the blood flow through the cortex
18. Positron emission tomography and its application to the study of cerebrovascular disease in man
19. Relationship of cerebral blood flow to cardiac output, mean arterial pressure, blood volume, and alpha and beta blockade in cats
20. Effects of sufentanil on cerebral blood flow, cerebral blood flow velocity and metabolism in dogs
21. Volume expansion in focal cerebral ischemia: The effect of cardiac output on local cerebral blood flow
22. Loss of cerebral regulation during cardiac output variations in focal cerebral ischemia
23. Hamodilution bei cerebralen durchblutungsstorungen. Indikation, durchfuhrung, medikamentose zusatzbehandlung und alternativen
24. Circadian variation of blood-pressure
25. Haemodilution in cerebral circulatory disturbances: Indications, implementation, additional drug treatment and alternatives
26. Custom-tailored haemodilution with albumin and crystalloids in acute ischemic stroke
27. Blood pressure during the first minutes of focal cerebral ischemia
28. Changes in plasma catecholamine levels after insula damage in experimental stroke
29. Blood pressure course in patients with acute stroke and matched controls
30. Very high blood pressure in acute stroke
31. Cerebral blood flow and metabolism in normotensive and hypertensive patients with transient neurologic deficits
32. Focal cerebral ischaemia and infarction due to antihypertensive therapy
33. Management of hypertension in patients with acute stroke
34. Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography
35. Monitoring and management of antihypertensive therapy induced deterioration in acute ischemic stroke
36. Changes of circadian blood pressure patterns after haemodynamic and thromboembolic brain infarction
37. Cardiac output in patients with acute stroke
38. Hyperdynamic therapy for focal cerebral ischemia in rats: Use of colloidal volume expansion and dobutamine
39. Reversal of ischemic neurological signs by increasing the cardiac output
40. Effect of blood pressure and diabetes on stroke in progression
41. Blutverdunnung bei zerebraler ischamie. Abschied von einem verbreiteten behandlungskonzept
42. Haemodilution in acute stroke, results of the Italian haemodilution trial
43. The Italian haemodilution trial in acute stroke
44. Neurological deterioration under isovolemic haemodilution with hydroxyethyl starch in acute cerebral ischemia
45. Multicenter trial of haemodilution in acute ischemic stroke
46. Multicenter trial of haemodilution in acute ischemic stroke. Results of subgroup analyses
47. Baseline hemodynamic state and response to hemodilution in patients with acute cerebral ischemia
48. Current status of hemodilution in acute cerebral ischemia
49. Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm
50. Influence of hypervolemic therapy of acute stroke with low molecular weight hydroxyethyl starch on haemodynamics
51. All medium starches are not the same: Influence of degree of substitution of hydroxyethyl starch on volume effect, haemorheologic conditions and coagulation
52. Comparison of hypervolaemic haemodilution concepts in acute stroke
53. Evaluation of longterm outcome and safety after hemodilution therapy in acute ischemic stroke
54. Hypervolemic hemodilution treatment of acute stroke, results of a randomized multicenter trial using pentastarch
55. A randomized controlled trial of hemodilution therapy in acute ischemic stroke
56. Adjusted hypervolemic hemodilution in acute ischemic stroke
57. Klinische ergebnisse einer doppelblinden, plazebokontrollierten, randomisierten isound hypervolamischen hamodilutionsstudie mit haes 200/0,5
58. Hypervolemic hemodilution in acute ischemic stroke. The Multicenter Austrian Hemodilution Stroke Trial (MAHST)
59. Coagulation disorders caused by hydroxyethyl starch
60. An international view of hydroxyethyl starches
61. Prognosis of stroke patients requiring mechanical ventilation in neurological critical care unit
62. Adverse effects of prolonged hyperventilation in patients with severe head injury: A randomized trial
63. Changes of cerebral perfusion after osmotherapy in acute cerebral edema assessed with perfusion weighted MRI
64. Transcranial Doppler-monitoring of intracranial pressure therapy with mannitol, sorbitol and glycerol in patients with acute stroke
65. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke
66. Tissue plasminogen activator for acute ischemic stroke
67. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study (ECASS)
68. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASSII)
69. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke
70. Termination of trial of streptokinase in severe acute ischaemic stroke
71. Thrombolytic therapy with streptokinase in acute ischemic stroke
72. Randomised controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischaemic stroke
73. The prolyse in acute cerebral thromboembolism trial (PROACT): Results of 6 mg dose tier
74. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke: A pilot study
75. Thrombolyse beim schlaganfall
76. Thrombolytic therapy of acute basilar artery occlusion
77. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in acute cerebral thromboembolism
78. Intraarterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease
79. Local intra-arterial fibrinolysis in the vertebrobasilar and carotid territories
80. Low molecular weight heparinoid, ORG 10172 (Danaparoid) and outcome after acute ischemic stroke
81. Intravenous heparin for acute stroke. What can we learn from the megatrials?
82. Pravention des hirninfarktes
83. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
84. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
85. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery
86. CAST: Randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke
87. Ischaemic cerebrovascular disease: Treatment with various anti-platelet aggregation drugs. Clinical follow-up of 80 patients (22-34 months)
88. Dipyridamole: A critical evaluation
89. CAPRIE trial
90. One year after CAPRIE, IST and ESPS 2. Any changes in concepts?
91. Normovolaemic induced hypertension therapy for cerebral vasospasm after subarachnoid haemorrhage
92. Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage
93. The impact of cardiac index on cerebral hemodynamics
94. TCD-Untersuchung uber den einfluss der hamodynamik auf die zerebrale autoregulation beim akuten hirninfarkt
95. Influence of blood pressure and cardiac output on cerebral blood flow and autoregulation in acute stroke measured by TCD
96. The effect of increased blood pressure on hemispheric lactate and water content during acute cerebral ischemia in the rat and gerbil
97. Relation between blood pressure and outcome in intracerebral hemorrhage
98. The j-curve phenomenon in stroke recurrence
99. Relationship between blood pressure and outcome in intracerebral haemorrhage
100. Why do all drugs work in animals but none in stroke patients? Drug promoting cerebral blood flow
101. Hypertension with haemodilution prevents multifocal cerebral hypoperfusion after cardiac arrest in dogs
102. Protective effect of Fluosol-DA in acute cerebral ischemia
103. Beneficial effects of isovolemic hemodilution using a perfluorocarbon emulsion in a stroke model
104. Use of Oxygent, a perfluorochemical-based oxygen carrier, as an alternative to intraoperative blood transfusion
105. Perfluorocarbons in the twenty-first century: Clinical applications as transfusion alternatives
106. Intravenous nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischemic stroke
107. Meta-analysis of oral nimodipine trials in acute ischemic stroke
108. Termination of acute stroke studies involving selfotel treatment
109. A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS)
110. The Clomethiazole Acute Stroke Study (CLASS): Results of a randomised controlled study of clomethiazole versus placebo in 1360 acute stroke patients
111. Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke
112. A randomized dose-response trial of citicoline in acute ischemic stroke patients
113. Decompressive surgery in space occupying hemispheric infarction: Results of an open, prospective trial